세계의 진단용 인공지능(AI) 시장 : 컴포넌트별, 진단별, 국가별, 지역별, 산업 분석, 시장 규모, 시장 점유율(2024-2032년)

REPORT HIGHLIGHT

Artificial Intelligence in Diagnostics Market size was valued at USD 1,567.12 Million in 2024, expanding at a CAGR of 22.5% from 2024 to 2032.

Artificial Intelligence in Diagnostics refers to the use of advanced algorithms and machine learning techniques to analyze medical data and assist in identifying diseases or conditions. By processing vast amounts of clinical information, imaging, and patient history, AI systems can detect patterns and anomalies often invisible to the human eye. This technology enhances accuracy, speeds up diagnosis, and supports healthcare professionals in making informed decisions. AI-driven diagnostics improve early disease detection, personalize treatment plans, and optimize healthcare outcomes while reducing errors and costs. It represents a transformative tool in modern medicine, integrating data science with clinical expertise.

Artificial Intelligence in Diagnostics Market- Market Dynamics

Rising Demand for Early and Accurate Disease Detection

The growing emphasis on early and precise diagnosis is a major driver for the AI in diagnostics market. Healthcare systems worldwide are prioritizing timely identification of diseases to improve patient outcomes and reduce treatment costs. Artificial Intelligence enhances diagnostic accuracy by swiftly analyzing complex datasets such as medical images, genetic profiles, and electronic health records. This capability supports early detection of conditions like cancer, cardiovascular diseases, and neurological disorders. As a result, hospitals, clinics, and diagnostic labs are increasingly adopting AI tools to minimize errors, accelerate diagnosis, and support personalized treatment decisions.

Artificial Intelligence in Diagnostics Market- Key Insights

According to our research analyst, the global Artificial Intelligence in Diagnostics Market is expected to develop at a CAGR of approximately 22.5% between 2024-2032.

Segmented by Component in 2024, the Software category dominated the market.

Based on Diagnosis, the Radiology segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Artificial Intelligence in Diagnostics Market- Segmentation Analysis:

The global Artificial Intelligence in Diagnostics Market is divided into Three categories: Component, Diagnosis, and Region.

The Artificial Intelligence in Diagnostics market is segmented by component into software, hardware, and services. Among these, software emerges as the dominant segment due to its central role in processing data, executing algorithms, and generating diagnostic outputs. AI-powered software solutions are integral for interpreting medical images, analyzing lab results, and supporting clinical decision-making. These platforms continuously evolve through machine learning, improving accuracy over time and adapting to complex diagnostic challenges. The growing integration of AI software with hospital systems, electronic health records (EHRs), and imaging equipment further strengthens its market leadership. Additionally, software solutions offer scalability, remote access, and cost-efficiency, making them more attractive to healthcare providers compared to hardware and service components, which often require higher upfront investments and infrastructure support.

The Artificial Intelligence in Diagnostics market, by diagnosis, is segmented into cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. Among these, radiology holds the dominant share due to the vast volume of imaging data it generates and the critical need for accurate interpretation. AI is revolutionizing radiology by enhancing the analysis of X-rays, MRIs, CT scans, and ultrasounds, enabling faster and more accurate detection of abnormalities such as tumors, fractures, and internal bleeding. The ability of AI algorithms to detect subtle patterns and reduce diagnostic errors makes them invaluable tools for radiologists. Furthermore, rising demand for imaging diagnostics, especially in chronic disease management and emergency care, continues to drive AI adoption in radiology, reinforcing its market leadership.

Artificial Intelligence in Diagnostics Market- Geographical Insights

Geographically, the Artificial Intelligence in Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Artificial Intelligence in Diagnostics market, primarily driven by the United States. The region benefits from a well-established healthcare infrastructure, significant investments in AI technologies, and supportive government initiatives. Leading tech firms and startups collaborate with hospitals to develop advanced diagnostic tools, especially in radiology and oncology. High adoption rates of electronic health records (EHRs), rising chronic disease prevalence, and increasing demand for precision medicine further fuel market growth. Regulatory bodies like the FDA actively approve AI-based diagnostic tools, boosting confidence in clinical applications. These factors position North America as a global leader in AI-driven diagnostic innovations.

Asia Pacific is emerging as a key growth region in the AI in Diagnostics market, led by countries such as China, Japan, and India. Rapid digital transformation in healthcare, growing investments in AI startups, and increasing government focus on health tech innovation are propelling market expansion. The region faces high patient volumes and rising incidences of chronic diseases, creating a strong demand for scalable, efficient diagnostic solutions. Additionally, initiatives like China's AI development plans and India's push for digital healthcare strengthen the ecosystem. Collaborations between local hospitals and global tech companies are accelerating AI adoption, making Asia Pacific a dynamic and rapidly expanding market.

Artificial Intelligence in Diagnostics Market- Competitive Landscape:

The competitive dynamics of the Artificial Intelligence in Diagnostics market are shaped by established healthcare and med-tech giants alongside agile startups driving innovation. Companies such as Siemens Healthineers, GE Healthcare, Aidoc, and Digital Diagnostics, Inc. dominate through robust AI platforms focused on medical imaging, cardiology, and pathology. These leaders prioritize R&D investments, regulatory compliance, and strategic partnerships to expand their AI portfolios. Meanwhile, emerging players like Vuno, Inc. and NovaSignal Corporation bring disruptive solutions, particularly in neurology and real-time data analysis. This healthy competitive mix promotes continuous product advancement, broader AI integration in diagnostics, and enhanced clinical decision support for healthcare professionals.

Recent Developments:

In March 2024, Aidoc partnered with the American College of Radiology to launch a nationwide clinical AI deployment initiative, enhancing stroke and pulmonary embolism detection.

In January 2025, Vuno, Inc. received European CE certification for its AI-powered VUNO Med-Chest X-ray(TM) solution, accelerating its expansion across EU healthcare systems.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Siemens Healthineers
• Zebra Technologies Corp.
• Riverain Technologies
• Vuno, Inc.
• Aidoc
• NovaSignal Corporation
• Imagen
• Digital Diagnostics, Inc.
• GE Healthcare
• AliveCor Inc.
• F. Hoffmann-La Roche Ltd
• Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY COMPONENT - MARKET ANALYSIS, 2019 - 2032

• Software
• Hardware
• Services

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY DIAGNOSIS - MARKET ANALYSIS, 2019 - 2032

• Cardiology
• Oncology
• Pathology
• Radiology
• Chest and Lung
• Neurology
• Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Artificial Intelligence in Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Artificial Intelligence in Diagnostics Market Snippet by Component
  • 2.1.2. Artificial Intelligence in Diagnostics Market Snippet by Diagnosis
  • 2.1.3. Artificial Intelligence in Diagnostics Market Snippet by Country
  • 2.1.4. Artificial Intelligence in Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. Artificial Intelligence in Diagnostics Key Market Trends

• 3.1. Artificial Intelligence in Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Artificial Intelligence in Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Artificial Intelligence in Diagnostics Market Opportunities
• 3.4. Artificial Intelligence in Diagnostics Market Future Trends

4. Artificial Intelligence in Diagnostics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Diagnostics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Diagnostics Market Landscape

• 6.1. Artificial Intelligence in Diagnostics Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Diagnostics Market - By Component

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
  • 7.1.2. Software
  • 7.1.3. Hardware
  • 7.1.4. Services

8. Artificial Intelligence in Diagnostics Market - By Diagnosis

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
  • 8.1.2. Cardiology
  • 8.1.3. Oncology
  • 8.1.4. Pathology
  • 8.1.5. Radiology
  • 8.1.6. Chest and Lung
  • 8.1.7. Neurology
  • 8.1.8. Others

9. Artificial Intelligence in Diagnostics Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Artificial Intelligence in Diagnostics Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Artificial Intelligence in Diagnostics Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.7. France
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.7.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.8. Italy
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.9. Spain
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.10. United Kingdom
    • 9.3.10.1. Overview
    • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.11. Russia
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.12. Netherlands
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.13. Sweden
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.14. Poland
    • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3.15. Rest of Europe
    • 9.3.15.1. Overview
    • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Artificial Intelligence in Diagnostics Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.8. South Korea
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.8.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.9. Japan
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Artificial Intelligence in Diagnostics Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Artificial Intelligence in Diagnostics Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Artificial Intelligence in Diagnostics Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Siemens Healthineers
  • 10.2.2. Zebra Technologies Corp.
  • 10.2.3. Riverain Technologies
  • 10.2.4. Vuno, Inc.
  • 10.2.5. Aidoc
  • 10.2.6. NovaSignal Corporation
  • 10.2.7. Imagen
  • 10.2.8. Digital Diagnostics, Inc.
  • 10.2.9. GE Healthcare
  • 10.2.10. AliveCor Inc.
  • 10.2.11. F. Hoffmann-La Roche Ltd
  • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us